anesulfonate and 10-to 15-fold increased resistance to Nmethyl-N'-nitro-N-nitrosoguanidine but is similar to the S3 parent in sensitivity to mitomycin C, UV radiation, and ,y-rays. In contrast to the results for cytotoxicity, the A6 variant and the S3 parent showed the same high susceptibility to EtMes induction of ouabain-resistant mutations. This is direct biological evidence that different alkylation lesions are normally responsible for mutagenic and cytotoxic effects. The S3 and A6 cell lines may differ in DNA repair capability specific to certain potentially lethal alkylation products. The comparative sensitivity of the A6 cells to alkylation mutagenesis may also prove useful in cell genetic studies by facilitating the generation of multiple mutants for recessive alleles and permitting exceptionaly sensitive detection of specific mutagenic effects.
American Type Culture Collection. By plating the sensitive HeLa S3 line in the presence of highly cytotoxic doses of EtMes, we obtained a clone (designated A6) that displays about 7-fold greater resistance to EtMes toxicity. This A6 isolate is also cross resistant to other simple monofunctional alkylating agentsexhibiting about 4-fold increased resistance to methyl methanesulfonate and 10-to 15-fold increased resistance to Nmethyl-N'-nitro-N-nitrosoguanidine but is similar to the S3 parent in sensitivity to mitomycin C, UV radiation, and ,y-rays. In contrast to the results for cytotoxicity, the A6 variant and the S3 parent showed the same high susceptibility to EtMes induction of ouabain-resistant mutations. This is direct biological evidence that different alkylation lesions are normally responsible for mutagenic and cytotoxic effects. The S3 and A6 cell lines may differ in DNA repair capability specific to certain potentially lethal alkylation products. The comparative sensitivity of the A6 cells to alkylation mutagenesis may also prove useful in cell genetic studies by facilitating the generation of multiple mutants for recessive alleles and permitting exceptionaly sensitive detection of specific mutagenic effects.
Genetic variation in sensitivity to alkylating agents is well known in bacteria and yeast (1) (2) (3) (4) (5) (6) and has also been observed in Drosophila (7) . Variant isolates generally show an increased sensitivity to the agent relative to that characteristic of the wild type, and the phenomenon is usually attributable to deficiency in DNA repair (8) . Low molecular weight alkylating agents such as methyl methanesulfonate (MeMes), ethyl methanesulfonate (EtMes), and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) react with DNA at various sites, resulting in stable alkylated base adducts, phosphotriesters, and apurinic sites due to hydrolysis of unstable products (9) (10) (11) . Observations that the cytotoxicity and the mutagenicity or carcinogenicity of particular compounds are not precisely correlated imply that different lesions may be important for these different manifestations of damage (12) (13) (14) . There is evidence that 06-alkylguanine is a principal promutagenic adduct (11, 15) but it is not yet clear what lesions may be most significant to lethality.
Certain types of alkylation damage are susceptible to repair. For example, 06-alkylguanine can be removed by excision (16, 17) . Some microbial mutants with increased sensitivity to inactivation by simple alkylating agents are evidently deficient in functions that are involved in nucleotide excision or postreplication repair pathways (4) . A base excision repair mode (18) involving DNA glycosylases and apurinic endonucleases seems to be important also. In addition to several types of chemical evidence indicating repair of alkylation damage in mammalian cells (16, 18, 19) , some information is available concerning properties of human cell strains from individuals with genetic diseases that affect repair processes. Xeroderma pigmentosum strains defective in excision of UV photoproducts show repair replication and virtually normal survival after exposure to MNNG (20, 21) . Fanconi anemia cells, deficient in crosslink repair. (22) , show normal survival after exposure to EtMes but both spontaneous and EtMes-induced mutations are suppressed (23) . Ataxia telangiectasia strains, unusually sensitive to ionizing radiation (24) , are also more sensitive to killing by MeMes and MNNG (25, 26 same sensitivity to EtMes as the parent population was isolated and used in the studies reported here. Cell stocks were maintained in serial culture for a maximum of 3 months and were then routinely renewed from frozen samples of the fresh clones. Basic cell culture procedures were as described (29) . Cells were grown at 370C in a-modified minimal essential medium (K.C. Biological, Lenexa, KS) supplemented with 5 or 10% fetal bovine serum (Flow Laboratories). Cell concentrations and size spectra were determined with an electronic cell counter and multichannel analyzer (Coulter). Assays for Cytotoxicity and Mutagenesis. The alkylating agents MeMes (Aldrich), EtMes, MNNG, and mitomycin C (all from Sigma) were freshly prepared at various concentrations in dimethyl sulfoxide. Monolayer cultures were inoculated with the appropriate stock solution (1% final dimethyl sulfoxide concentration) and incubated at 370C for 3 hr (except that exposures to EtMes were for 16 hr). Treatments were terminated by changing the medium, and shortly thereafter the samples were trypsinized, plated to determine relative viability, and subcultured if necessary for later mutagenesis assays.
In experiments in which only cell survival was assayed, treatments with alkylating agent were carried out on replicate cultures in exponential growth at 2-5 X 106 cells per 75 cm2 plastic culture flask (one-quarter to one-half confluence). Cultures twice this size in 150-cm2 plastic flasks or 1-liter prescription bottles were used for experiments in which induced mutation as well as cytotoxicity was to be assayed. In the latter case, after plating to determine survival, the treated samples were subcultured about every third day for 7-10 days after mutagen treatment to allow expression of induced mutations. At these passages, cultures were diluted by no more than 1:5 from confluence in order to minimize dilution of induced mutants present in relatively small numbers. After this expression period, the samples were plated in medium containing 1 uM ouabain to measure the frequency of ouabain-resistant mutants (30, 31) . These selective platings were inoculated at 5 X 105 to 2 X 106 cells per 100-mm culture dish; a control experiment confirmed that recovery of phenotypically resistant colonies was linear with cell inoculum over this range (32) . In most experiments we assayed from each mutagenized culture a minimum of either 107 cells or enough cells to yield about 200 mutant colonies. The mutagenized cultures exhibited virtually normal plating efficiencies in nonselective medium (nt50%) at the time of selection for mutants, and data for mutant frequency are therefore reported without correction for relative viability.
For y-ray exposures, replicate cultures were seeded as for treatments with alkylating agents but were then trypsinized and resuspended in 10 ml of growth medium for irradiation. Samples of S3 and A6 cells were irradiated simultaneously in a 137CsC12 gamma-cell 40 apparatus (Atomic Energy Canada) at a dose rate of 145 R/min (0.4 coulomb/kg per min) and then were plated for viability testing.
For UV irradiation, cells from exponentially growing cultures were first plated at 2 X 102 to 8 X 104 cells per 100-mm culture dish. About 6 hr later, the medium was removed and uncovered dishes were exposed to a 40-W germicidal lamp at 70 cm for the desired interval, medium was replaced immediately, and the dishes were incubated for colony formation. Control dishes were treated identically but without exposure to radiation. To circumvent artifacts caused by shadowing of the radiation at the peripheries of the dishes, only colonies lying within a 70-mm-diameter central disc were scored.
The plating assays were incubated without disturbance for 10, 12, and 14 days, respectively, for S3, A6, and CCL2 cells. Colonies Survival data for one of these clones, designated A6, is shown in Fig. 1 binding and susceptibility of Na,+K+-ATPase to this specific inhibitor (31, 33) . [At present this is the only well-characterized marker available for single-step mutagenesis assays with HeLa cells. We could not compare one-step recessive mutations to thioguanine-resistance (29) , for example, presumably because of aneuploidy at the X-linked hprt locus.]
The results from two sets of mutagenesis experiments are shown in Fig. 2 . Over the dose range 0-0.2 mM EtMes, in which the frequency of mutants increases rapidly by >2 orders of magnitude with increasing EtMes, the dose-dependence of induction of ouabain-resistant mutants was virtually identical in the two cell lines. Fig. 2A also shows that up to 2 mM EtMes, at which mutants cannot be recovered from the S3 strain due to-cytotoxicity of the mutagen, the frequency of induced mutants in the A6 line continued to increase gradually to 1000 times the frequency found in untreated control cultures.
In its responsiveness to low mutagen doses, the A6 variant (like the S3 parent) differed markedly from the HeLa CCL2 line. The latter cells required at least 10-fold greater doses of EtMes, in excess of 2 mM, to increase the frequency of ouabain-resistant mutants to approximately 10-5 per cell assayed (Table 1) .
In these experiments, an interval of 7-10 days was allowed between mutagen treatment and assay of ouabain-resistant cells to permit expression of the induced mutant phenotypes and also recovery and growth of surviving cells. In order to confirm that this expression time was suitable for quantitation of the induced dominant mutations, and to compare the kinetics of mutant expression in the S3 and A6 cell lines, frequencies of ouabainresistant mutants were also determined as a function of time after mutagen treatment. Results are shown in Fig. 3 of ouabain-resistant mutants assayed in untreated control cultures was <7 X 10-8. At zero expression time (i.e., when the 16-hr mutagen exposure was terminated), the frequency of mutants recovered from mutagenized S3 cells was also <7 X 10-8 whereas the mutant frequency among mutagenized A6 cells was more than 10-fold above that level. (This difference in immediate responses may have been due to the different mutagen concentrations used on the two cell lines.) The mutant frequency in both S3 and A6 cultures increased rapidly for about 3 days after EtMes treatment; then it leveled off and did not change substantially for at least 10 days thereafter. Hence, we infer that the 7-to 10-day expression times used in our experiments were appropriate for maximal detection of induced mutants.
To evaluate the cross resistance of the A6 isolate to other monofunctional alkylating agents, we compared the cytotoxicities of MeMes and MNNG for the S3 and A6 clones. In both cases the A6 cells retained appreciable viability at doses that decreased S3 survival to 0.1% of control (Fig. 4) . In terms of D10 for MeMes toxicity, the A6 isolate was about 4-fold more resistant than the S3 parent, although in the lower survival range the slopes of the curves did not differ much (Fig. 4A) . By conlo-4l trast, in different experiments the DIo of the A6 isolate for MNNG was 10-to 15-fold that of the S3 parent and the survival curves diverged at an increasing rate with increasing lethality (Fig. 4B) . Together with the data in Fig. 1 , these results indicate that the relative resistance exhibited by A6 cells to inactivation by these alkylating agents falls in the order MNNG > EtMes > MeMes. Assays for the induction of ouabain-resistant mutants by MNNG showed that, as with EtMes, the A6 isolate was not more resistant than the S3 parent to mutagenesis by low doses of the alkylating agent (data not shown).
The S3 and A6 cell lines were also compared for sensitivity to killing by the bifunctional alkylating agent mitomycin C, by UV radiation, and by y-rays. The data in Fig. 5 show that the responses of the two clones were similar in each case. Due to small differences in the shoulders of the curves, the Dio of the A6 line for UV appears to be increased about 20% relative to that of S3 (Fig. 5B) , and the DIo of A6 for y-rays seems about 30% less than that of S3 (Fig. SC) .
The S3 and A6 cells were similar with respect to cell volume in exponential growth and chromosome content. The median cell volume of A6 in exponential growth was approximately 2400 ,um3 and that of S3 was about 2700 ,m3; in both cases, chromosome numbers clustered in the range 80-90. The doubling time of A6 cells in exponential growth was approximately 30 hr compared to about 20 hr for S3 cells. The differences in phenotype between the two cell lines were stable over periods of several months in serial culture.
DISCUSSION
The point of departure for this work was our observation that a HeLa S3 cell line was markedly more sensitive to EtMes cytotoxicity and mutagenesis than was the HeLa CCL2 cell line from the American Type Culture Collection. Because these lines can be assumed to derive from a common ancestor and because the susceptibility of the CCL2 line to EtMes is similar to that found for normal human diploid fibroblasts (30, 34) , we suppose that in the course of its culture history one or more mutations have been inadvertantly fixed in the S3 line to cause its sensitivity to alkylation damage. Indeed, we have observed by chance a clone of ouabain-resistant CCL2 cells that displays an enhanced sensitivity to EtMes toxicity comparable to that found in the S3 line (unpublished data). The S3 line was used for further studies of EtMes sensitivity because mutagenesis could be monitored through assays of dominant mutations to ouabain resistance (31, 32) . To provide an alternative to simple comparison of the S3 and CCL2 cell lines, which have different growth properties and have probably diverged at a number of genetic loci, we selected S3 cells for increased resistance to EtMes and obtained the A6 clone. The A6 clone could be revertant for a trait previously altered in the parental S3 line or it may have acquired a new property conferring resistance to EtMes toxicity. It differs from the resistant CCL2 line, however, in retaining exceptional sensitivity to EtMes mutagenesis. Because the A6 isolate was obtained after treatment with substantial EtMes doses, its genotype also may differ from that of the S3 parent at multiple loci.
It is remarkable that, although the A6 isolate exhibits substantially increased resistance to the cytotoxicity of simple monofunctional alkylating agents, it does not differ from the S3 parent with respect to the dose dependence of mutant induction. The existence of such variants provides graphic proof to support previous inferences that the cytotoxicity of these agents is not due to induction of lethal mutations per se (35) . Further, it confirms that even different alkylation products in the DNA must be responsible for the cytotoxic and mutagenic effects, as has been proposed from comparative analyses of dose-response relationships for chemical and biological effects (13, 14) and also from genetic variation in adaptive repair of mutagenic and cytotoxic alkylation damage in Escherichia coli (36) . Indeed, although there is evidence that 06-alkylguanine adducts are promutagenic (15) , the principal lethal lesions have not been identified and it cannot yet be excluded that they reside elsewhere than in the DNA. The relative degrees of resistance to toxicity shown by the A6 variant increase in the order MeMes < EtMes < MNNG. These agents cause somewhat different spectra of reaction products, and the observed progression of resistance correlates with increasing frequency of SN1 products whose formation involves unimolecular reaction kinetics (13) , suggesting that it is damage in this category that is preferentially toxic in the sensitive S3 cells.
It seems likely that the A6 isolate differs from the parental S3 line in activity of a DNA repair process affecting potentially lethal bht not mutagenic lesions in the DNA. An alternative possibility is that the A6 cells are less susceptible to formation of the class of lesions that is cytotoxic. The fact that the A6 cells show unaltered sensitivity to mutagenesis indicates that their phenotype cannot be explained on the basis of decreased permeability or accessibility of the genome. The differences between the S3 and CCL2 cells are consistent with altered permeability, although our preliminary assays indicated that they differ by no more than 2-fold in [3H]EtMes uptake (unpublished data). The comparable responses of the S3 and A6 cells to mitomycin C and UV radiation imply that the lines do not differ significantly in repair of interstrand and intrastrand DNA crosslinks. The EtMes-sensitive S3 parent is, if anything, slightly more resistant to y-rays than is the A6 isolate, implying different processes in repair of the inactivating damage from ionizing radiation and alkylation. It is conceivable that the differences between the two cell lines could stem from altered activity of a specific DNA glycosylase or apurinic endonuclease. We found no evidence for inducible repair analogous to the adaptive response in E. colt (37) for the S3, A6, or CCL2 line. Cultures that had been maintained in marginally toxic doses of MNNG or EtMes for a week or more showed no appreciable changes in dose dependence of cell killing when challenged with higher doses of the agent (data not shown).
We expect that comparative biochemical studies of the cell lines described here should aid in distinguishing potentially lethal and mutagenic alkylation products and in characterizing relevant reaction or repair processes. Furthermore, several types of Chinese hamster ovary cells variants that exhibit striking increases in sensitivity to alkylating agents or other mutagens will be available (L. H. Thompson, personal communication). The HeLa A6 line or analogous variants, in particular, should also be of considerable practical value in cell culture. First, preferential susceptibility to heavy mutagenesis may ease selections for recessive traits that require mutation of multiple wild-type alleles. Second, such lines will provide an exceptionally sensitive assay for potential mutagens of the appropriate specificity (32) . As shown here for the case of EtMes induction of ouabain-resistance, a dramatic increase in mutations can be discerned at doses that are both an order of magnitude lower than those that are appreciably toxic and an order of magnitude lower than the doses necessary to produce a comparable response in normal human cells.
